What is Curaxis Pharmaceutical Capex-to-Operating-Income?
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.
Curaxis Pharmaceutical Capex-to-Operating-Income Historical Data
The historical data trend for Curaxis Pharmaceutical's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Curaxis Pharmaceutical's Capex-to-Operating-Income
For the Drug Manufacturers - General subindustry, Curaxis Pharmaceutical's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curaxis Pharmaceutical's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curaxis Pharmaceutical's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where Curaxis Pharmaceutical's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
Curaxis Pharmaceutical Capex-to-Operating-Income Related Terms
Thank you for viewing the detailed overview of Curaxis Pharmaceutical's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Curaxis Pharmaceutical (Curaxis Pharmaceutical) Business Description
Curaxis Pharmaceutical Corp was incorporated in Delaware on February 27, 2001. It is a specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease. The Company's therapeutic platform is based on the hypothesis that diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. This drug development platform is built on the premise that hormones associated with this feedback loop are beneficial early in life, when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised, thereby leading to disease processes, including pathologies associated with Alzheimer's disease and various cancers. Its discovery of similar hormonal signaling mechanisms at the cellular level in brain tissue from Alzheimer's patients and in multiple tumors will enable it to develop significant new treatments for Alzheimer's disease and may have applications for many cancers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CURXQ has been successfully added to your